ARCHIVES

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group Clinical Trials Approved

November 27, 2009

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

October 25, 2013

ACS Concludes That Laetrile Organization Is Insignificant

November 29, 1991

Femara Better Suppressor Of Estrogen, Study Finds

February 22, 2002

In Brief: Lasker Foundation Will Not Make 1990 Awards; Michigan Cancer Elects Fischer Vice Chairman

March 2, 1990

ICCCR Participants Honor Cullen, Blast Tobacco Industry

March 15, 1991